Israel CRISPR Gene Detection and Diagnostic Market to 2032
Overview
The Israel CRISPR Gene Detection and Diagnostic Market is expected to reach a 13.42 USD Million by 2032 and is projected to grow at a CAGR of 14.86% from 2025 to 2032.
Israel CRISPR Gene Detection and Diagnostic Market 2018-2032 USD Million
Israel CRISPR Gene Detection and Diagnostic Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 6.15 USD Million
- Projected Market Size (2032): 13.42 USD Million
- CAGR (2025-2032): 14.86%
Key Findings of Israel CRISPR Gene Detection and Diagnostic Market
- The Israel CRISPR Gene Detection and Diagnostic Market was valued at 6.15 USD Million in 2024.
- The Israel CRISPR Gene Detection and Diagnostic Market is likely to grow at a CAGR of 14.86% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Class-2 Single CrRNA-Binding Protein in Class Segment accounted for the largest share of the market with a revenue of 5.43 USD Million
- The fastest growing segment Biotechnology Companies in End User Segment grew Fastest with a CAGR of 19.53% during the forecast period from 2024 to 2032.
Israel CRISPR Gene Detection and Diagnostic Market Scope
- Others
- Hospitals
- Diagnostic Centers
- Academic and Research Institutes
- Biotechnology Companies
- Retail Sales
- Direct Tender
- Sensing
- Sample Preparation
- Pre-Amplification
- Cas Enzyme
- CRRNA
- Services
- Products
- Others
- Drug Discovery
- Genome Engineering
- Agricultural Applications
- Biomedical Diagnostics
- Class-1 Multiple Effector Proteins
- Class-2 Single CrRNA-Binding Protein
Israel CRISPR Gene Detection and Diagnostic Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 6.15 USD Million |
| Market Value in 2032 | 13.42 USD Million |
| CAGR (2025-2032) | 14.86% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Distribution Channel,Workflow,Products and Services,Application,Class |
Regional Insights:
-
Leading Market (2024-2032): Israel, leading in terms of revenue 6.15 USD Million in 2024
- Key Country: Israel, leading in terms of revenue with value of 6.15 USD Million in 2024.
Segments and Scope
-
Israel CRISPR Gene Detection and Diagnostic Market to 2032, By End User
- Biotechnology Companies is the largest segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 2.99 USD Million in the year 2024.
- Biotechnology Companies is the Fastest growing segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 19.53 % in forecast period 2025-2032.
-
Israel CRISPR Gene Detection and Diagnostic Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 2.76 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 18.95 % in forecast period 2025-2032.
-
Israel CRISPR Gene Detection and Diagnostic Market to 2032, By Workflow
- CRRNA is the largest segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 2.26 USD Million in the year 2024.
- CRRNA is the Fastest growing segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 19.24 % in forecast period 2025-2032.
-
Israel CRISPR Gene Detection and Diagnostic Market to 2032, By Products and Services
- Products is the largest segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 4.14 USD Million in the year 2024.
- Products is the Fastest growing segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 15.85 % in forecast period 2025-2032.
-
Israel CRISPR Gene Detection and Diagnostic Market to 2032, By Application
- Biomedical Diagnostics is the largest segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 3.68 USD Million in the year 2024.
- Biomedical Diagnostics is the Fastest growing segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 17.02 % in forecast period 2025-2032.
-
Israel CRISPR Gene Detection and Diagnostic Market to 2032, By Class
- Class-2 Single CrRNA-Binding Protein is the largest segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 5.43 USD Million in the year 2024.
- Class-2 Single CrRNA-Binding Protein is the Fastest growing segment in Israel CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 15.61 % in forecast period 2025-2032.
Israel CRISPR Gene Detection and Diagnostic Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| Agilent Technologies, Inc. | |||
| 10x Genomics | |||
| GenScript | |||
Israel CRISPR Gene Detection and Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Million
Israel CRISPR Gene Detection and Diagnostic Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Israel CRISPR Gene Detection and Diagnostic Market Scope
- Others
- Hospitals
- Diagnostic Centers
- Academic and Research Institutes
- Biotechnology Companies
- Retail Sales
- Direct Tender
- Sensing
- Sample Preparation
- Pre-Amplification
- Cas Enzyme
- CRRNA
- Services
- Products
- Others
- Drug Discovery
- Genome Engineering
- Agricultural Applications
- Biomedical Diagnostics
- Class-1 Multiple Effector Proteins
- Class-2 Single CrRNA-Binding Protein
Frequently Asked Questions
Israel CRISPR Gene Detection and Diagnostic Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.